{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:30:39Z","timestamp":1789817439808,"version":"4.0.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1097\/mcp.0000000000000409","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T19:48:43Z","timestamp":1497556123000},"page":"458-467","source":"Crossref","is-referenced-by-count":47,"title":["Ocular sarcoidosis"],"prefix":"10.1097","volume":"23","author":[{"given":"Sung J.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherveen","family":"Salek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20200527","first-page":"5","article-title":"Clinical features of ocular sarcoidosis in patients with biopsy-proven pulmonary sarcoidosis in serbia.","volume":"1-","author":"Radosavljevic","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R2-14-20200527","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00415-016-8336-4","article-title":"Neurosarcoidosis: a clinical approach to diagnosis and management","volume":"264","author":"Ibitoye","year":"2016","journal-title":"J Neurol"},{"key":"R3-14-20200527","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R4-14-20200527","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ajo.2010.05.036","article-title":"Scale for photographic grading of vitreous haze in uveitis","volume":"150","author":"Davis","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R5-14-20200527","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/09273941003753416","article-title":"Scleral nodule and bilateral disc edema as a presenting manifestation of systemic sarcoidosis","volume":"18","author":"Babu","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"R6-14-20200527","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R7-14-20200527","first-page":"7","article-title":"Spectrum of uveitis in a German tertiary center: review of 474 consecutive patients.","volume":"1-","author":"Grajewski","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"R8-14-20200527","first-page":"8","article-title":"The Kkesh Uveitis Survey Study Group. Patterns of uveitis in a tertiary care referral institute in Saudi Arabia.","volume":"1-","author":"Al Dhibi","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R9-14-20200527","first-page":"8","article-title":"Patterns and etiologies of uveitis at a tertiary referral center in Taiwan.","volume":"1-","author":"Chen","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R10-14-20200527","first-page":"7","article-title":"Clinical patterns of uveitis in tertiary ophthalmology centers in Seoul, South Korea.","volume":"1-","author":"Lee","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R11-14-20200527","first-page":"7","article-title":"Frequency of Uveitis in the Central Tokyo Area (2010-2012).","volume":"1-","author":"Nakahara","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R12-14-20200527","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10792-015-0128-9","article-title":"Patterns of uveitis at the Apex Institute for Eye Care in India: results from a prospectively enrolled patient data base (2011-2013)","volume":"36","author":"Venkatesh","year":"2016","journal-title":"Int Ophthalmol"},{"key":"R13-14-20200527","first-page":"7","article-title":"Land of the long white cloud: the spectrum of uveitis at a tertiary referral center in New Zealand.","volume":"1-","author":"Wong","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R14-14-20200527","first-page":"10","article-title":"Demographic and clinical characteristics of uveitis in Turkey: the first national registry report.","volume":"1-","author":"Yalcindag","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R15-14-20200527","first-page":"8","article-title":"Etiology and clinical features of ocular inflammatory diseases in a tertiary referral centre in Sydney, Australia.","volume":"1-","author":"Zagora","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R16-14-20200527","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00153496","article-title":"Risk factors for ocular sarcoidosis","volume":"72","author":"Rothova","year":"1989","journal-title":"Doc Ophthalmol"},{"key":"R17-14-20200527","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2147\/OPTH.S83950","article-title":"Causes of uveitis in children without juvenile idiopathic arthritis","volume":"9","author":"Engelhard","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"R18-14-20200527","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/art.22122","article-title":"Pediatric granulomatous arthritis: an international registry","volume":"54","author":"Rose","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R19-14-20200527","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/09273940902818861","article-title":"International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS)","volume":"17","author":"Herbort","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"R20-14-20200527","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.reuma.2015.12.008","article-title":"Diagnostic categorization according to the First International Workshop on Ocular Sarcoidosis (FIWOS) criteria in a series of 11 patients","volume":"13","author":"Meneses","year":"2017","journal-title":"Reumatol Clin"},{"key":"R21-14-20200527","first-page":"237","article-title":"Ocular and systemic features of sarcoidosis and correlation with the International Workshop for Ocular Sarcoidosis diagnostic criteria","volume":"32","author":"Agrawal","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R22-14-20200527","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12348-016-0105-0","article-title":"Assessment of vitreous haze using ultra-wide field retinal imaging","volume":"6","author":"Dickson","year":"2016","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R23-14-20200527","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ajo.2013.12.005","article-title":"Comparison of wide-field fluorescein angiography and 9-field montage angiography in uveitis","volume":"157","author":"Nicholson","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R24-14-20200527","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/02713683.2013.834938","article-title":"Systematic analysis of wide-field fundus autofluorescence (FAF) imaging in posterior uveitis","volume":"39","author":"Reznicek","year":"2014","journal-title":"Curr Eye Res"},{"key":"R25-14-20200527","first-page":"8","article-title":"Clinical manifestations, complications and treatment of ocular sarcoidosis: correlation between visual efficiency and macular edema as seen on optical coherence tomography.","volume":"1-","author":"Paovic","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"R26-14-20200527","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jcjo.2013.10.005","article-title":"Optical coherence tomography in the diagnosis and management of uveitis","volume":"49","author":"Pakzad-Vaezi","year":"2014","journal-title":"Can J Ophthalmol"},{"key":"R28-14-20200527","first-page":"138","article-title":"Cigarette smoking and male sex are independent and age concomitant risk factors for the development of ocular sarcoidosis in a New Orleans sarcoidosis population","volume":"32","author":"Janot","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R29-14-20200527","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ophtha.2015.01.003","article-title":"Sarcoidosis in the national veteran population: association of ocular inflammation and mortality","volume":"122","author":"Birnbaum","year":"2015","journal-title":"Ophthalmology"},{"key":"R30-14-20200527","first-page":"6","article-title":"High resolution chest computerized tomography in the diagnosis of ocular sarcoidosis in a high TB endemic population.","volume":"1-","author":"Babu","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R31-14-20200527","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12886-016-0194-4","article-title":"The serum angiotensin converting enzyme and lysozyme levels in patients with ocular involvement of autoimmune and infectious diseases","volume":"16","author":"Sahin","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"R32-14-20200527","doi-asserted-by":"crossref","first-page":"e0147258","DOI":"10.1371\/journal.pone.0147258","article-title":"Interleukin-2 receptor and angiotensin-converting enzyme as markers for ocular sarcoidosis","volume":"11","author":"Gundlach","year":"2016","journal-title":"PLoS One"},{"key":"R33-14-20200527","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/bjophthalmol-2015-307455","article-title":"Lymphopenia as a predictor of sarcoidosis in patients with uveitis","volume":"100","author":"Jones","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"R34-14-20200527","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/IAE.0000000000000312","article-title":"Choroidal granulomas visualized by enhanced depth imaging optical coherence tomography","volume":"35","author":"Invernizzi","year":"2015","journal-title":"Retina"},{"key":"R35-14-20200527","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2016.08.035","article-title":"Quantifying retinal microvascular changes in uveitis using spectral-domain optical coherence tomography angiography","volume":"171","author":"Kim","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R36-14-20200527","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1167\/iovs.14-15118","article-title":"Aqueous cell differentiation in anterior uveitis using Fourier-domain optical coherence tomography","volume":"56","author":"Rose-Nussbaumer","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R37-14-20200527","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1167\/iovs.16-20324","article-title":"Association of high-mobility group box-1 with Th cell-related cytokines in the vitreous of ocular sarcoidosis patients","volume":"58","author":"Takeuchi","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R39-14-20200527","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mvr.2015.03.008","article-title":"Vascular function and ocular involvement in sarcoidosis","volume":"100","author":"Siasos","year":"2015","journal-title":"Microvasc Res"},{"key":"R40-14-20200527","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.yexmp.2015.07.002","article-title":"Orbital pseudotumor can be a localized form of granulomatosis with polyangiitis as revealed by gene expression profiling","volume":"99","author":"Rosenbaum","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"R41-14-20200527","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.preteyeres.2015.11.001","article-title":"Molecular diagnosis: implications for ophthalmology","volume":"50","author":"Rosenbaum","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"R42-14-20200527","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/jamaophthalmol.2015.0726","article-title":"Parallel gene expression changes in sarcoidosis, involving the lacrimal gland, orbital tissue, or blood","volume":"133","author":"Rosenbaum","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"R43-14-20200527","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1167\/iovs.13-12660","article-title":"Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study","volume":"55","author":"Sheppard","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R44-14-20200527","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1097\/IAE.0000000000000515","article-title":"Efficacy and safety of dexamethasone intravitreal implant for persistent uveitic cystoid macular edema","volume":"35","author":"Khurana","year":"2015","journal-title":"Retina"},{"key":"R45-14-20200527","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ophtha.2006.02.021","article-title":"Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study","volume":"113","author":"Jaffe","year":"2006","journal-title":"Ophthalmology"},{"key":"R46-14-20200527","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2011.07.027","article-title":"Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial","volume":"118","author":"Kempen","year":"2011","journal-title":"Ophthalmology"},{"key":"R47-14-20200527","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/IIO.0000000000000070","article-title":"Clinical trials in noninfectious uveitis","volume":"55","author":"Kim","year":"2015","journal-title":"Int Ophthalmol Clin"},{"key":"R48-14-20200527","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.ophtha.2016.07.029","article-title":"Intravitreal sirolimus for noninfectious uveitis: a phase III sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA)","volume":"123","author":"Nguyen","year":"2016","journal-title":"Ophthalmology"},{"key":"R49-14-20200527","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N Engl J Med"},{"key":"R50-14-20200527","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive noninfectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet"},{"key":"R51-14-20200527","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaapos.2015.12.006","article-title":"Treatment of pediatric uveitis with adalimumab: the MERSI experience","volume":"20","author":"Castiblanco","year":"2016","journal-title":"J AAPOS"},{"key":"R52-14-20200527","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.semarthrit.2015.05.010","article-title":"Anti-TNF-alpha therapy in refractory uveitis associated with sarcoidosis: multicenter study of 17 patients","volume":"45","author":"Riancho-Zarrabeitia","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"R53-14-20200527","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1097\/MD.0000000000000559","article-title":"Evaluation of microincision vitrectomy surgery using wide-viewing system for complications with ocular sarcoidosis","volume":"94","author":"Takayama","year":"2015","journal-title":"Medicine (Baltimore"}],"container-title":["Current Opinion in Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCP.0000000000000409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:28:19Z","timestamp":1620959299000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00063198-201709000-00014"}},"subtitle":["new diagnostic modalities and treatment"],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mcp.0000000000000409","relation":{},"ISSN":["1070-5287"],"issn-type":[{"value":"1070-5287","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}